chr3-43080213-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_032806.6(POMGNT2):c.1219C>T(p.Arg407Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00034 in 1,614,084 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R407Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_032806.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POMGNT2 | NM_032806.6 | c.1219C>T | p.Arg407Trp | missense_variant | 2/2 | ENST00000344697.3 | |
POMGNT2 | XM_005265515.4 | c.1219C>T | p.Arg407Trp | missense_variant | 3/3 | ||
POMGNT2 | XM_011534163.3 | c.1219C>T | p.Arg407Trp | missense_variant | 3/3 | ||
POMGNT2 | XM_017007353.2 | c.1219C>T | p.Arg407Trp | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POMGNT2 | ENST00000344697.3 | c.1219C>T | p.Arg407Trp | missense_variant | 2/2 | 1 | NM_032806.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000559 AC: 85AN: 152170Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000203 AC: 51AN: 250824Hom.: 0 AF XY: 0.000147 AC XY: 20AN XY: 135622
GnomAD4 exome AF: 0.000317 AC: 463AN: 1461796Hom.: 1 Cov.: 37 AF XY: 0.000278 AC XY: 202AN XY: 727188
GnomAD4 genome AF: 0.000558 AC: 85AN: 152288Hom.: 0 Cov.: 33 AF XY: 0.000618 AC XY: 46AN XY: 74468
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 01, 2021 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 27535533) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 09, 2023 | - - |
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 30, 2013 | DNA sequence analysis of the POMGNT2 gene demonstrated a sequence change, c.1219C>T, in exon 2 that results in an amino acid change, p.Arg407Trp. This sequence change does not appear to have been previously described in patients with POMGNT2-related disorders and has been described in the Exome Aggregation Consortium with a low population frequency of 0.025% (dbSNP rs138480528). The p.Arg407Trp change affects a moderately conserved amino acid residue located in a domain of the POMGNT2 protein that is not known to be functional. The p.Arg407Trp substitution appears to be deleterious/possibly damaging using several in-silico pathogenicity prediction tools (SIFT PolyPhen2, MutationTaster). Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Arg407Trp change remains unknown at this time. - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 407 of the POMGNT2 protein (p.Arg407Trp). This variant is present in population databases (rs138480528, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with POMGNT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 129214). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt POMGNT2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at